T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Clinical trials for T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA trials appear
Sign up with your email to follow new studies for T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in preventing relapse after transplant for rare blood cancers
Disease control CompletedThis study tested whether a low dose of the drug chidamide, given after a stem cell transplant, could help prevent T-cell acute lymphoblastic leukemia or T-cell lymphomas from coming back. 44 patients aged 14-70 who had a transplant took chidamide as maintenance therapy. The main…
Matched conditions: T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
Experimental combo aims to boost stem cell transplant success for rare blood cancers
Disease control CompletedThis early-phase study tested whether adding the drug romidepsin to standard chemotherapy before and after a stem cell transplant could help control T-cell cancers like lymphoma and leukemia. Researchers enrolled 23 adults to find the safest dose and see if the combination helped…
Matched conditions: T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:52 UTC